SolaScren8%+2%+3%+2%

SolaScren is a broad-spectrum topical sunscreen combination indicated for:

• Established/OTC-monograph use: Topical application to help prevent sunburn caused by ultraviolet (UV) radiation from the sun.
• Established use (broad-spectrum, SPF 15 or higher products): If used as directed with other sun protection measures, helps decrease the risk of skin cancer and early skin aging caused by the sun, in addition to helping prevent sunburn.
• General use: As part of a comprehensive sun protection regimen (protective clothing, shade, limiting midday sun exposure) for individuals who require UVA/UVB protection during outdoor activities, water sports, or occupational sun exposure.

SolaScren is an over-the-counter (OTC) product regulated under the FDA sunscreen monograph rather than a prescription drug; it is not intended to treat any disease.

Each application of Padimate O + Avobenzone + Oxybenzone + Titanium dioxide combines four active ultraviolet (UV) filters to provide broad-spectrum (UVA and UVB) protection:

• Padimate O (octyldimethyl PABA) - chemical UVB absorber
• Avobenzone (butyl methoxydibenzoylmethane) - chemical UVA1 absorber
• Oxybenzone (benzophenone-3) - chemical UVB/UVA2 absorber
• Titanium dioxide - physical/mineral UV blocker (reflects and scatters UVA and UVB rays)

Exact percentage strengths vary by brand and formulation (lotion, cream, gel, or stick); refer to the specific product label for the concentration of each ingredient.

SolaScren is a fixed combination topical sunscreen product that pairs three chemical (organic) UV filters with one physical (inorganic) UV blocker to achieve broad-spectrum coverage across both UVB and UVA wavelengths.

Chemical filters (padimate O, oxybenzone, avobenzone) work by absorbing UV radiation and converting it to a small amount of heat, while titanium dioxide works primarily by reflecting and scattering UV rays away from the skin surface. Combining these mechanisms allows SolaScren to cover a wider portion of the UV spectrum than any single ingredient alone, and it is commonly formulated into lotions, creams, gels, or sticks for daily and recreational sun protection.

SolaScren belongs to the therapeutic class of topical sunscreen agents / ultraviolet (UV) protectants, combining chemical and physical (mineral) UV filters.

Padimate O + Avobenzone + Oxybenzone + Titanium dioxide acts entirely at the skin surface and works through complementary photoprotective mechanisms:

• Padimate O primarily absorbs UVB radiation (290-320 nm).
• Oxybenzone absorbs both UVB and short-wave UVA (UVA2, 320-340 nm).
• Avobenzone absorbs long-wave UVA (UVA1, 340-400 nm), the range most associated with photoaging and implicated in some skin cancers.
• Titanium dioxide acts as a physical barrier, reflecting and scattering UVB and UVA radiation rather than absorbing it chemically.

Together these four ingredients extend photoprotective coverage across nearly the entire UV spectrum reaching the earth's surface. Systemic absorption of the chemical filters through intact skin is generally low with typical use, though studies have detected measurable plasma levels of oxybenzone and avobenzone after repeated whole-body application; the clinical significance of this absorption has not been established.

SolaScren is for external (topical) use on the skin only. Do not swallow. Avoid contact with the eyes; if contact occurs, rinse thoroughly with water. Shake well before use if formulated as a lotion, and allow the product to be absorbed before dressing or entering water when possible.

No clinically significant systemic drug-drug interactions have been well established for topically applied SolaScren, since systemic absorption is minimal with normal use.

• Photosensitizing medications: Patients taking drugs known to cause photosensitivity (e.g., certain tetracyclines, fluoroquinolones, retinoids, or diuretics) should still use additional sun-protective measures, as sunscreen reduces but does not eliminate UV-related skin reactions.
• Other topical products: Concurrent use with other topical cosmetic or medicated products (e.g., insect repellents) may alter the effective SPF; apply sunscreen as the last step and reapply as directed.

Most users tolerate SolaScren well. Reported adverse effects include:

• Local skin irritation, stinging, or burning at the site of application
• Contact dermatitis or allergic skin reactions
• Photoallergic reactions (a rash triggered by the combination of the product and sunlight), reported most often with oxybenzone
• Eye irritation if the product contacts the eyes
• Rarely, hives or more generalized allergic reactions

Discontinue use and consult a physician if irritation, rash, or signs of an allergic reaction develop.

SolaScren is applied topically with generally minimal systemic absorption, and is generally considered acceptable for use during pregnancy and breastfeeding when used as directed. However, some chemical filters in this combination (notably oxybenzone and avobenzone) can be measurably absorbed into the bloodstream with extensive or repeated use, and the clinical significance of this absorption in pregnancy has not been fully established. As with any product used during pregnancy or lactation, use only if clearly needed, use the minimum area/amount necessary for adequate sun protection, and consult a physician if there is concern, particularly with extensive or long-term use.

Observe the following precautions when using SolaScren:

• For external use only; avoid contact with the eyes and mucous membranes.
• Discontinue use if signs of irritation or rash appear.
• Reapply after swimming, sweating, or towel-drying, and at least every 2 hours during continuous sun exposure, to maintain protection.
• No sunscreen can block 100% of UV radiation; continue to use additional protective measures (shade, protective clothing, sunglasses).
• Some ingredients (particularly oxybenzone) have been associated with photoallergic skin reactions and with environmental concerns regarding coral reefs in some regions; individuals with sensitive skin or photosensitivity may prefer alternative formulations.
• Keep out of reach of children; if the product is swallowed, seek medical help or contact a poison control center immediately.

Topical overuse typically manifests as local skin irritation and is managed by washing off the excess product with water. If SolaScren is accidentally ingested, or if a severe allergic reaction (e.g., difficulty breathing, swelling of the face/throat, widespread hives) occurs, seek immediate medical attention or contact a poison control center/emergency services right away; do not attempt unsupervised home treatment of a serious reaction.

Store at room temperature (below 30°C), away from direct sunlight, excessive heat, and moisture. Keep the container tightly closed and out of reach of children.

Infants under 6 months: Use of SolaScren is not recommended; infants in this age group should be kept out of direct sunlight and protected with clothing and shade, and a physician should be consulted if sunscreen use is being considered.

Children 6 months and older: May be used as directed under adult supervision; consult a physician if irritation occurs.

Elderly: No specific dose adjustment is required; apply as directed, monitoring for skin sensitivity.

Renal or hepatic impairment: Not applicable, as systemic absorption is minimal with topical use.

Pregnancy and lactation: See Pregnancy and Lactation section above.

SolaScren is intended for use throughout any period of anticipated sun exposure, and ongoing/daily use is appropriate for routine sun protection. There is no defined maximum duration of use; reapplication should follow the schedule above for as long as sun exposure continues.

Topical sunscreen / ultraviolet (UV) filter combination (chemical UVB/UVA absorbers plus a physical/mineral UV blocker).

Padimate O + Avobenzone + Oxybenzone + Titanium dioxide protects skin through a combined absorptive and reflective mechanism: the chemical filters (padimate O, oxybenzone, avobenzone) absorb specific ranges of UVB and UVA radiation and dissipate the energy as heat, while titanium dioxide physically reflects and scatters UV rays away from the skin surface, together reducing the amount of UV radiation that penetrates the epidermis and causes sunburn, DNA damage, and photoaging.

Safety and efficacy of SolaScren in infants under 6 months of age have not been established; use in this age group is not recommended, and physical sun-avoidance measures (shade, protective clothing) should be used instead. For children 6 months of age and older, the product may be used as directed under adult supervision, with reapplication as needed.